More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speedPLEASANTON, Calif., June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clinical Platform applications to simplify and streamline medical device and diagnostics studies. With increasing regulat ...

MIAMI, June 11, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, today announced the appointment of Dr. James Lee to its scientific advisory board (SAB) to help guide development of PAS-004 for the treatment of ETS2 pathway inflammatory diseases including inflammatory bowel disease (IBD), ulcerative colitis, Crohn’s disease, primary sclerosing cholangitis ...

"Autonomous vehicle companies are under mounting pressure from rising video storage demands and infrastructure costs," said Sharon Carmel, Beamr CEO. "Our content-adaptive technology, accelerated by GPUs, delivers highly efficient compression while maintaining visual quality across a variety of scenarios - both for human perception and machine vision, and in both real-world and synthetic video." In recent benchmark testing on raw driving footage using real-time object detection models, Beamr's CABR achieved ...

SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis will be presented today in a poster session at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, which is taking place June 11- 14, 2025 in Barcelona. The poster will be presented by Gonçalo Boleto, M.D., MSc, a rheumatologist a ...

New design demonstrates end-to-end energy-efficient cooling and power to support densities up to142kW per rackCOLUMBUS, Ohio, June 11, 2025 /PRNewswire/ -- Vertiv (NYSE: VRT), a global leader in critical digital infrastructure, announced its energy-efficient 142kW cooling and power reference architecture for the NVIDIA GB300 NVL72 platform. In addition to fully integrated end-to-end cooling and power strategies for this next generation platform, the reference architecture unlocks a new era of infrastructure ...

Trend Secure AI Factory supports NVIDIA NeMo continuous model safety evaluation and improvement lifecycleDALLAS, June 11, 2025 /PRNewswire/ -- Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today announced its adoption of the NVIDIA Agentic AI Safety blueprint, enhancing foundational security to help ensure customers' AI systems are protected across their full development and deployment lifecycle.To read more about how Trend enhances security across NVIDIA Enterprise AI fact ...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DIRTT Environmental Solutions Ltd (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, has qualified to trade on the OTCQX® Best Market. DIRTT Environmental Solutions Ltd upgraded to OTCQX from the Pink® market. DIRTT Environmental Solutions Ltd begins trading today on OTCQX under the symbol “DRTTF.” U.S. investors ...

To register to attend BIO 2025, visit convention.bio.org. About BIO FRIENDSWOOD, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, founder, president and chief executive officer of Castle Biosciences, will participate in a panel discussion alongside other industry leaders during the 2025 BIO International Convention (BIO 2025), being held June 16-19 in Boston. The ...

The event will include presentations from Ligand's senior management team highlighting the company's strategy, investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand's Investor Relations website at investor.ligand.com. A detailed agenda, including dial-in information, will be provided closer to the event. About Ligand Pharmaceuticals Investors: Melanie Herman investors@ligand.com (858) 550-7761 Media: Kellie Walsh media@ligand.c ...

WILMETTE, Ill. and HOUSTON, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ("Monopar," the "Company," "us" and "our") (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, in collaboration with Excel Diagnostics and Nuclear Oncology Center ("EDNOC"), a premier diagnostic medical imaging and therapeutic nuclear medicine center, today announced that the physician-sponsored Expanded Access Program ("EAP" ...